GCTK — GlucoTrack Share News
0.000.00%
Last trade - 00:00Brief: Glucotrack Achieves Key Compliance Milestone And Advances Strategic Transformation
Brief: Glucotrack Enters Amendment No. 1 To Stock Purchase Agreement With White Lion Capital
NASDAQ RESUMED AT 03:23 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 03:18 PM
Brief: Lōkahi Therapeutics™ Advances Lt-100 Development Strategy Toward Single-Injection Administration
GlucoTrack's Q1 net loss narrows
Brief: Glucotrack To File Significant Ide With FDA For Us Clinical Trial In Early Q2 Based On Critical 2025 Milestones
NASDAQ RESUMED AT 02:02 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 01:57 PM
NASDAQ RESUMED AT 09:47 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:42 AM
Brief: Glucotrack Enters Purchase Agreement With Sixth Borough Capital - SEC Filing
Exclusive: Former Lockton exec Taiym joining life insurance tech firm Integrity as global COO
Brief: Glucotrack And Onetwo Analytics Present Positive Final Results Continuous Blood Glucose Monitor
Brief: Glucotrack Reports First Quarter 2025 Financial Results And Recent Corporate Highlights
Brief: Glucotrack And Onetwo Analytics To Collaborate For Clinical Study Analysis On Its Continuous Blood Glucose Monitor
Brief: Glucotrack, Inc. Announces Pricing Of $3.0 Million Public Offering
Brief: Glucotrack Announces Successful Completion of Its First Human Clinical Study of Continuous Blood Glucose Monitor
Brief: Glucotrack Receives Nasdaq Notice For Bid Price Non-Compliance